Wattana Karnpaet PCL (BKK:NEW) Equity-to-Asset: 0.82 (As of Jun. 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NEW Wattana Karnpaet PCL BKK:NEW
81 GF Score
Price ฿92.75
GF Value ฿98.26
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wattana Karnpaet PCL Equity-to-Asset?

Wattana Karnpaet PCL BKK:NEW 81 Equity-to-Asset is 0.82 as of Jun. 2026, which is 14% above its 10-year median of 0.72. GuruFocus rates BKK:NEW with a GF Score™ of 81/100 and a GF Value™ of ฿98.26 (Fairly Valued). The stock has 2 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks better than 87.77% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Wattana Karnpaet PCL's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ฿525.0 Mil. Wattana Karnpaet PCL's Total Assets for the quarter that ended in Jun. 2026 was ฿640.8 Mil. Therefore, Wattana Karnpaet PCL's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.82.

The historical rank and industry rank for Wattana Karnpaet PCL's Equity-to-Asset or its related term are showing as below:

BKK:NEW' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.65   Med: 0.72   Max: 0.85
Current: 0.82

During the past 13 years, the highest Equity to Asset Ratio of Wattana Karnpaet PCL was 0.85. The lowest was 0.65. And the median was 0.72.

BKK:NEW's Equity-to-Asset is ranked better than
87.77% of 687 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs BKK:NEW: 0.82

Wattana Karnpaet PCL  (BKK:NEW) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Wattana Karnpaet PCL Equity-to-Asset Related Terms


Wattana Karnpaet PCL Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Wattana Karnpaet PCL's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wattana Karnpaet PCL Equity-to-Asset Chart

Wattana Karnpaet PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.77 0.78 0.82 0.83

Wattana Karnpaet PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.82 0.83 0.85 0.82

BKK:NEW vs HCA, THC, EHC: Equity-to-Asset Comparison

For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wattana Karnpaet PCL Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Wattana Karnpaet PCL's Equity-to-Asset falls into.


BKK:NEW
81GF Score
Wattana Karnpaet PCL BKK:NEW
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wattana Karnpaet PCL Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Wattana Karnpaet PCL's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=523.49477007/632.62055245
=0.83

Wattana Karnpaet PCL's Equity to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Equity to Asset (Q: Jun. 2026 )=Total Stockholders Equity/Total Assets
=525.04125153/640.76842436
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.82 mean?
Wattana Karnpaet PCL (BKK:NEW) has a Equity-to-Asset of 0.82 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Wattana Karnpaet PCL and its competitors. This is 14% above median its historical median of 0.72. Over the past decade, Wattana Karnpaet PCL's Equity-to-Asset has ranged from 0.65 to 0.85. According to the industry distribution chart, Wattana Karnpaet PCL ranks #84 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Wattana Karnpaet PCL's Equity-to-Asset too high?
Wattana Karnpaet PCL's current Equity-to-Asset of 0.82 is 14% above median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 0.85. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Wattana Karnpaet PCL's value of 0.82 is 67.3% above this industry median. Based on the distribution chart, Wattana Karnpaet PCL ranks #84 out of 687 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Wattana Karnpaet PCL has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #84 out of 687 companies for Equity-to-Asset. This places Wattana Karnpaet PCL in the top 12% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.49. Wattana Karnpaet PCL's value of 0.82 is 67.3% above this benchmark. Historically, Wattana Karnpaet PCL's own Equity-to-Asset has ranged from 0.65 to 0.85 over the past decade. While the company's 10-year median is 0.72 vs. the industry median of 0.49, Wattana Karnpaet PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattana Karnpaet PCL's current Equity-to-Asset of 0.82 is 67.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current Equity-to-Asset is 0.82, which is 14% above median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿98.26, compared to a current price of ฿92.75 — trading 5.6% below its estimated fair value. The current Equity-to-Asset is 0.82, which is 14% above median its 10-year median of 0.72 and 67.3% above the Healthcare Providers & Services industry median of 0.49. Wattana Karnpaet PCL's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current Equity-to-Asset is 0.82 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?

Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued. The current stock price of ฿92.75 is trading 5.6% below its estimated GF Value™ of ฿98.26. GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.

Key valuation signals for BKK:NEW:

  • Equity-to-Asset: 0.82 (14% above median its 10-year median of 0.72)
  • GF Value™: ฿98.26 vs. price of ฿92.75 (5.6% below fair value)
  • GF Score™: 81/100 with 2 warning signs
  • Industry Position: 67.3% above the Healthcare Providers & Services median (#84 of 687)

No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wattana Karnpaet PCL Business Description

Address 70/7-8 Suphakitjanya Road, Mhakkang sub-district, Muang Udonthanee district, Udonthanee, THA, 41000
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
81GF Score

Get the complete analysis for BKK:NEW

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿92.75
Price
฿98.26
GF Value